Your search returned 2 results.

Results
	1.	Randomized phase III trial of paclitaxel/carboplatin with or without PF-3512676 (Toll-like receptor 9 agonist) as first-line treatment for advanced non-small-cell lung cancer. [electronic resource] by Hirsh, Vera Paz-Ares, Luis Boyer, Michael Rosell, Rafael Middleton, Gary Eberhardt, Wilfried E E Szczesna, Aleksandra Reiterer, Pavel Saleh, Mansoor Arrieta, Oscar Bajetta, Emilio Webb, Roy T Raats, Johannes Benner, Rebecca J Fowst, Camilla Meech, Sandra J Readett, David Schiller, Joan H Producer: 20110906 In: Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 29 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	EMPIRE Registry, Czech Part: Impact of demographics, pulmonary function and HRCT on survival and clinical course in idiopathic pulmonary fibrosis. [electronic resource] by Doubková, Martina Švancara, Jan Svoboda, Michal Šterclová, Martina Bartoš, Vladimír Plačková, Martina Lacina, Ladislav Žurková, Monika Binková, Ilona Bittenglová, Radka Lošťáková, Vladimíra Merta, Zdeněk Šišková, Lenka Tyl, Richard Lisá, Pavlína Šuldová, Hana Petřík, František Pšikalová, Jana Řihák, Vladimír Snížek, Tomáš Reiterer, Pavel Homolka, Jiří Musilová, Pavlína Lněnička, Jaroslav Palúch, Peter Hrdina, Roman Králová, Renata Hortvíková, Hana Strenková, Jana Vašáková, Martina Producer: 20181003 In: The clinical respiratory journal vol. 12 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)